Weight Loss Medications to Treat Obesity

Tune in to learn about the promise and pitfalls of weight loss medications, with Dr. Fatima Cody Stanford, an obesity medicine physician.

This episode focuses on a popular medication called semaglutide, which is sold as Ozempic or Wegovy. Dr. Stanford explains how this drug works and shares the good, the bad, and the ugly sides of what to expect. We also discuss how medications fit into the broader picture of obesity management and why Dr. Stanford is a vocal advocate for defining and treating obesity as a chronic disease. 

Dr. Stanford is an internationally recognized leader in obesity medicine. She practices and teaches at Massachusetts General Hospital (MGH) and is Associate Professor of Medicine and Pediatrics at Harvard Medical School (HMS). Dr. Stanford received her BS and MPH from Emory University as an MLK Scholar, her MD from the Medical College of Georgia School of Medicine as a Stoney Scholar, her MPA from the Harvard Kennedy School of Government as a Zuckerman Fellow in the Harvard Center for Public Leadership, and her executive MBA as a merit-based scholarship recipient from the Quantic School of Business and Technology. She completed her Obesity Medicine & Nutrition Fellowship at MGH/HMS after completing her internal medicine and pediatrics residency at the University of South Carolina. Dr. Stanford is also the recipient of numerous awards for her leadership, advocacy, and service.

Connect with Dr. Fatima Cody Stanford
Twitter @askdrfatima
Instgram @askdrfatima
Disclosures: Dr. Stanford has advised or consulted for: Novo Nordisk, Calibrate, GoodRX, Pfizer, Boehringer Ingelheim, Gelesis, Eli Lilly, Rhythm, MelliCell, Vida Health, Vira Health, Sweetch